Ebos Group Ltd (NZSE:EBO)

NZ$ 35.49 0.36 (1.02%) Market Cap: 6.81 Bil Enterprise Value: 8.39 Bil PE Ratio: 24.21 PB Ratio: 2.67 GF Score: 86/100

Half Year 2024 EBOS Group Ltd Earnings Call Transcript
Feb 20, 2024

NZ$35.8 (-2.48%)

Earnings
EBOS Group Ltd Annual Shareholders Meeting Transcript
Oct 24, 2023
Full Year 2023 EBOS Group Ltd Earnings Call Transcript
Aug 22, 2023

NZ$34.05 (-0.15%)

Earnings
Half Year 2023 EBOS Group Ltd Earnings Call Transcript
Feb 21, 2023

NZ$43.05 (+0.70%)

Earnings
Full Year 2022 EBOS Group Ltd Earnings Presentation Transcript
Aug 23, 2022
Half Year 2022 EBOS Group Ltd Earnings Presentation Transcript
Feb 15, 2022
EBOS Group Ltd Annual Shareholders Meeting Transcript
Oct 19, 2021
Full Year 2021 EBOS Group Ltd Earnings Call Transcript
Aug 17, 2021

NZ$31.4 (+0.64%)

Earnings
Half Year 2021 EBOS Group Ltd Earnings Call Transcript
Feb 16, 2021

NZ$29.17 (-1.29%)

Earnings
EBOS Group Ltd Annual Shareholders Meeting Transcript
Oct 13, 2020
Preliminary 2020 EBOS Group Ltd Earnings Call Transcript
Aug 19, 2020

NZ$21.9 (+0.09%)

Earnings
Half Year 2020 EBOS Group Ltd Earnings Call Transcript
Feb 19, 2020

NZ$23.35 (-1.06%)

Earnings
Full Year 2019 EBOS Group Ltd Earnings Call Transcript
Aug 21, 2019

NZ$24.5 (+1.20%)

Earnings

Full Year 2023 EBOS Group Ltd Earnings Call Transcript

Aug 22, 2023 / 11:30PM GMT

Release Date Price: NZ$34.05 (-0.15%)

Transcript

Operator

Thank you for standing by, and welcome to EBOS Group Limited FY '23 Full Year Results Conference Call. (Operator Instructions) again, I must advise you that this conference is being recorded today, the 23rd of August 2023. I would now like to hand the conference over to your first speaker today, Mr. John Cullity, CEO, EBOS Group. Please go ahead, John. Thank you.

John Cullity

EBOS Group Limited - CEO

Thank you, Maggie, and welcome, everyone, to EBOS Group's Full Year 2023 Results Presentation. My name is John Cullity, I'm the CEO for the EBOS Group, and I'm joined this morning by both Leonard Hansen, our CFO; and Martin Krauskopf, our EGM for Strategy, M&A and Investor Relations.

I'm very pleased to report that EBOS has achieved another record result driven by both organic growth and acquisitions completed in the prior year, particularly our LifeHealthcare business. The defensive and diversified nature of our portfolio of businesses is reflected in the result with both our Healthcare and Animal Care segments delivering double-digit underlying

Already have an account? Log in

Get the full story

Start 7-Day Free Trial

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

30-Day 100% money back guarantee

You are not charged until the trial ends. Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us ETF Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.